发明名称 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST
摘要 The present invention relates to novel piperidine derivatives, stereoisomers thereof or pharmaceutically acceptable salts thereof; methods for preparing the compound; and pharmaceutical compositions comprising the compound. The novel piperidine derivatives, according to the present invention, having an effect as GPR119 agonist can be used for treatment of metabolic disorders, including diabetes mellitus (especially type II) and related disorders.
申请公布号 US2015166480(A1) 申请公布日期 2015.06.18
申请号 US201314407214 申请日期 2013.06.11
申请人 CHONG KUN DANG PHARMACEUTICAL CORP. 发明人 Lee ChangSik;Jang TaegSu;Choi DaeKyu;Ko MooSung;Kim DoHoon;Kim SoYoung;Min JaeKi;Kim WooSik;Lim YoungTae
分类号 C07D211/22;C07D401/14;C07D405/12;C07D401/12;C07D409/12 主分类号 C07D211/22
代理机构 代理人
主权项 1. A piperidine derivative of the following formula 1, stereoisomers thereof or pharmaceutically acceptable salts thereof: wherein W is O or N—Rh; Ra, Rb and Rh are each independently H or C1-3 alkyl; Rc is —F or —C1-3 hyperfluoride alkyl; Rd and Re are each independently selected from the group consisting of H, halogen, —C1-5 alkyl and —C3-7 cycloalkyl, wherein —C1-5 alkyl and —C3-7 cycloalkyl are each independently unsubstituted or substituted with halogen, —CN, —OC1-5 alkyl or —C1-5 alkyl; or Rd and Re are combined to form a —C3-7 cycloalkyl, wherein the —C3-7 cycloalkyl is unsubstituted or substituted with halogen, —OC1-5 alkyl or —C1-5 alkyl;is selected from the group consisting of:wherein Rf1 and Rf2 are each independently H, halogen, —C1-5 alkyl, —C1-5 alkyl(OH), —OC1-5 alkyl or —CN;is selected from the group consisting of:wherein Rk1 and Rk2 are each independently H, halogen, —C1-5 alkyl, —C1-5 alkyl(OH), —OC1-5 alkyl or —CN;Q is H, —S(O)R1, —S(O)2R1, —C(O)R1, —C(O)OR1, —C(O)NHR1, —C(O)NR2R3, —S(O)2NHR1, —S(O)2NR2R3 or wherein R1 is H, —CF3, —C1-5 alkyl, 3 to 7-membered heterocyclic ring, C3-7 cycloalkyl, or Ar, R2 and R3 are each independently C1-5 alkyl, C3-7 cycloalkyl, 3 to 7-membered heterocyclic ring or Ar (in R1, R2 and R3, —C1-5 alkyl, 3 to 7-membered heterocyclic ring, C3-7 cycloalkyl and Ar may be each independently substituted with Rx1 and Rx2), or R2 and R3 together with the N atoms to which they are bonded may form a 5- or 6-membered heterocyclic aromatic or non-aromatic ring compound further having 0 to 3 members selected independently from the group consisting of N, O, S and C(O), wherein the heterocyclic aromatic or non-aromatic ring compound may be substituted with Rx1 and Rx2, wherein Ar is C6 monocyclic aromatic compound; or 5- or 6-membered heteroaryl group comprising 1 to 3 members selected from the group consisting of N, O and S, wherein Rx1 and Rx2 are each independently H, —OH, halogen, —CN, —CF3, 3- to 7-membered heterocyclic ring, —C1-5 alkyl, —C3-7 cycloalkyl, —C1-5 alkyl(OH), —C1-5 alkyl(OR4), —C1-5 alkyl(halogen), —C(O)NR4R5, —C(O)R4, —C(O)OR4, —S(O)2R4, —OR4,wherein R4 and R5 are each independently H, —C1-5 alkyl or —C3-7 cycloalkyl.
地址 Seoul KR